Used primarily in the treatment of osteoporosis in postmenopausal women and men, this compound helps increase bone mass and reduce the risk of fractures, particularly in the spine and hip. It is also prescribed for the treatment of glucocorticoid-induced osteoporosis and Paget's disease of bone. By inhibiting bone resorption, it slows bone loss and supports skeletal strength over time. The compound is typically administered orally in tablet form, taken on an empty stomach to ensure proper absorption. Regular use contributes to long-term reduction in fracture incidence and improved bone density in patients with compromised bone structure.